Windy Ayustyas Trisna, Sahudi Sahudi, Etty Hary Kusumastuti

Abstract views = 104 times | downloads = 110 times


Background:  Globocan data in 2018 shows the cancer incidence in Indonesia. The highest case in women is breast cancer. The chance of survival for patients with high malignancy (Grade III) is only 11.86%, while for patients with low malignancy (Grade I) can reach 71.69%. Estrogen exposure is a risk factor for breast cancer. The hormone causes its effect through the estrogen receptor which is a core protein. Patients with positive receptor have 5 and 10 years survival rate which is better than patients with negative estrogen receptor. Objective:  To identify the correlation between hormonal status of estrogen receptor and malignancy degree of invasive ductal breast cancer.  Material and Method:  This research is an observational analytic study. The sample used was patient medical record data in 2015-2017 in Anatomical Pathology Unit, Central Laboratory Installation, Dr. Soetomo General Hospital.  Results:  The data used was 694 patients medical record in 2015-2017. Approximately 56 patients (86%) had hormonal status of positive estrogen receptor with grade I cancer, 180 patients (70%) were in grade II, and 217 patients (45%) were in grade III. Approximately 9 patients (14%) had hormonal status of negative estrogen receptor with grade I cancer, 71 patients (28%) were in grade II, and 161 patients (34%) were in grade III. The result using Chi-Square test found Chi-Square value in the amount of 27.413 with a significance value of 0.000 (p <0.01).  Conclusion:  There is a positive correlation between the hormonal status of estrogen receptor and malignancy degree of invasive ductal breast cancer.


Invasive Ductal Breast Cancer, Estrogen Receptor, ER, Malignancy Degree

Full Text:



Bauer, Katrina R. et al. 2007. "Descriptive Analysis Of Estrogen Receptor (ER)- Negative, Progesterone Receptor (PR)-Negative, And HER2-Negative Invasive Breast Cancer, The So- Called Triple-Negative Phenotype". Cancer 109.9: 1721-1728.

Kementrian Kesehatan Republik Indonesia. 2019. Hari Kanker Sedunia 2019. Jakarta. Avaialable at 2019.html (Retrieved 6 June 2019).

National Breast Cancer Foundation. 2016. Invasive Ductal Carcinoma. Available at (Retrieved 6 June 2017).

Payne, S.J.L. Bowen, R.L. Jones, J.L. Wells, C.A. 2008. Predictive markers in breast cancer-the present. Histopathology; 52: p 82-90.

Pecorino, L. 2012. Molecular Biology Of Cancer. Oxford: Oxford University Press.

Price, S.A. Wilson, L.M. 2006. Patofisiologi: Konsep Klinis Proses- Proses Penyakit. Jakarta: EGC

Safitriana, A. Yazid, N. Suprijono, A. 2010. Hubungan Antara Derajat Diferensiasi dengan Adanya Reseptor Estrogen Pada Penderita Karsinoma Payudara Jenis Duktus Invasif. Universitas Diponegoro. Avaialable at (Retrieved 7 June 2017).

WHO. 2017. Cancer. Available at (Retrieved 6 June 2017).

Zanellia, Q. 2012, “Hubungan Status Hormonal Estrogen dengan Derajat Keganaan Kanker Payudara Duktal Invasif di Departemen SMF/Patologi Anatomi (FK Unair – RSUD Dr. Soetomo Surabaya)” Universitas Airlangga.


  • There are currently no refbacks.

Copyright (c) 2021 Majalah Biomorfologi

Creative Commons License
Majalah Biomorfologi (p-ISSN:0215-8833e-ISSN:2716-0920) is licensed under a Creative Commons Attribution 4.0 International License.

View Majalah Biomorfologi Statistics


 Indexed By




Universitas Airlangga, Kampus C Mulyorejo, Surabaya 60115, East Java, Indonesia